The 3CTN EDI Framework and Toolkit is Launched
The Canadian Cancer Clinical Trials Network (3CTN) and its collaborative partners are thrilled to announce the launch of an Equity, Diversity, and Inclusion (EDI) Framework and companion Toolkit designed to support the Canadian research community in embedding EDI best practices within clinical trial conduct! This comprehensive EDI Framework and Toolkit resource are the products of an expert working group comprised of 3CTN members, trial sponsors, and people with lived experience from underrepresented communities. The resulting materials are available and accessible on the 3CTN website for the benefit of all in the research community. To access, please go to https://3ctn.ca/equity-diversity-and-inclusion-in-clinical-trials/.

Applications for the CIHR Institute of Cancer Research's annual ECR Workshop are now open. Application deadline: September 30, 2024. Learn more here:
CanPath, in partnership with the University of Toronto’s Dalla Lana School of Public Health, will provide a webinar on Wednesday June 24th (Noon to 1:00 pm EDT) on how large population cohorts can respond in a pandemic and support rapid national research efforts. ...